Table 1.

Adult patients with juvenile idiopathic arthritis (JIA)-associated uveitis were treated with tocilizumab when refractory to topical corticosteroids and systemic immunosuppression.

Patient	Age^*/sex	ILAR Classification	HLA-B27/ANA/RF	JIA Diagnosis at Age, yrs	Uveitis Diagnosis at Age, yrs	Uveitis Type^**	Involved Eyes	Complications
1	18 M	Oligoarthritis, ext.	Neg/pos/neg	4	5	Anterior	Both	Cataract, synechiae, glaucoma
2	18 F	Polyarthritis	Neg/pos/neg	11	11	Anterior	Both	Cataract, synechiae
3	19 F	Polyarthritis	Neg/pos/neg	3	15	Anterior	Left	Cataract, synechiae, macular edema, glaucoma

↵* At time of starting tocilizumab therapy.
↵** Standardization of Uveitis Nomenclature classification⁷. ANA: antinuclear antigen; RF: rheumatoid factor; ILAR: International League of Associations for Rheumatology.